Lifestyle Changes Through Exercise and Nutrition (LEAN)
The Lifestyle Changes Through Exercise and Nutrition (LEAN) Project
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Louisiana
-
Baton Rouge, Louisiana, Estados Unidos, 70808
- Pennington Biomedical Research Center
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- self-identify as African American
- a member of a participating church
- age 18-75 years old
- BMI > 30
- own a mobile phone with text message capabilities
- at risk for diabetes (diagnosed nuclear family member or gestational diabetes) or diagnosed with type 2 diabetes
- willing to provide written informed consent
- willing to change diet, physical activity and weight
- able to participate in face-face counselling sessions as scheduled
- low to moderate cardiovascular disease risk
Exclusion Criteria:
- currently participating in a weight loss program
- currently using weight loss medication or have lost weight (>10 lbs in last year)
- planning to move from the area within the next year
- given birth within the past year, are currently pregnant or plan to become pregnant within the next year
- planning to have bariatric surgery within 2 years
- history of major depression, suicidal behavior or eating disorder
- hospitalization for a mental disorder or substance abuse in the last year
- have cancer or had cancer within the past 5 years.
- serious heart problems such as arrhythmias, cardiomyopathy, congestive heart failure
- stroke or heart attack in the last six months
- high blood pressure [systolic ≥160, or diastolic ≥100]
- chronic inflammatory conditions, including but not limited to severe arthritis, lupus, or inflammatory bowel disease
- diseases that are life threatening or that can interfere with or be aggravated by exercise or weight loss
- unwilling or unable to provide informed consent
- physician's or principal investigator's decision to exclude
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Weight loss intervention
Churches randomized to the intervention condition will receive the community health coach delivered church based intervention for 6 months followed by 6 months of weight maintenance.
|
The intervention will involve utilizing trained community health coaches to deliver the weight loss intervention.
There will be 10 group based sessions conducted at each church over 6 months.
Session frequency will be 4 weekly sessions (4) for the first month, bimonthly sessions for 2 months (4) and monthly sessions for 2 months (2).
The study is based upon weight loss strategies that have been utilized in the Diabetes Prevention Program.
The group sessions will be augmented by utilizing text messages.
The text messages will be delivered weekly and three types of messages will be delivered: 1) lesson content, 2) motivational, 3) behavioral prompts.
|
|
Experimental: Delayed Treatment Control Group
Churches in the delayed treatment control condition will receive information on various health topics relevant to African Americans, such as strokes, lupus, sickle cell, etc. via text message during the first six months.
Participants in this group will not receive any behavioral strategies designed to alter weight, physical activity, or diet during this time.
They will receive the community health coach delivered church based weight loss intervention after 6 months.
|
The intervention will involve utilizing trained community health coaches to deliver the weight loss intervention.
There will be 10 group based sessions conducted at each church over 6 months.
Session frequency will be 4 weekly sessions (4) for the first month, bimonthly sessions for 2 months (4) and monthly sessions for 2 months (2).
The study is based upon weight loss strategies that have been utilized in the Diabetes Prevention Program.
The group sessions will be augmented by utilizing text messages.
The text messages will be delivered weekly and three types of messages will be delivered: 1) lesson content, 2) motivational, 3) behavioral prompts.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Percent weight loss
Periodo de tiempo: Month 6 and Year 1
|
Percent weight loss will be calculated at 6 and 12 months.
|
Month 6 and Year 1
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Body Fat Percentage
Periodo de tiempo: Screening, Month 6 and Year 1
|
The participant's body fat percentage is measured using the portable Tanita Body Composition Analyzer (SC-240).
|
Screening, Month 6 and Year 1
|
|
Change in Blood Glucose
Periodo de tiempo: Screening, Month 6 and Year 1
|
The Alere Cholestech LDX® Analyzer is engineered to provide accurate, actionable, and readily accessible glucose testing results.
The Cholestech uses fingerstick sampling and small sample size (40μL) that makes results less time consuming and easy to obtain.
|
Screening, Month 6 and Year 1
|
|
Change in Blood Pressure
Periodo de tiempo: Screening, Month 6 and Year 1
|
Blood pressure will be measured using an automatic blood pressure cuff (Omeron, Model BP710 or similar).
Participants will rest for approximately 5 minutes prior to blood pressure measurement to ensure accurate at rest reading.
|
Screening, Month 6 and Year 1
|
|
Change in Food Intake
Periodo de tiempo: Screening, Month 6 and Year 1
|
The National Cancer Institute (NCI) fat screener estimates the percentage of energy from fat by asking patients to report the frequency of consuming specific foods over the past 12 months.
A standard 7-item fruit and vegetable screener developed by the NCI and National 5 a Day Program grantees asks how often fruit and vegetables were consumed in the past month.
|
Screening, Month 6 and Year 1
|
|
Change in Physical activity
Periodo de tiempo: Screening, Month 6 and Year 1
|
The International Physical Activity Questionnaire (IPAQ) questionnaire is a self-report measure of physical activity.
The metabolic equivalent task (MET) minutes in each domain of leisure time activity, that is, sedentary, light, moderate, and vigorous intensity, will be calculated.
The IPAQ has been shown to be a reliable and valid measure of physical activity and has been sensitive to changes in physical activity resulting from intervention programs.
|
Screening, Month 6 and Year 1
|
|
Change in Quality of Life
Periodo de tiempo: Screening, Month 6 and Year 1
|
. Each participant's quality of life will be assessed using the Impact of Weight on Quality of Life Survey.
|
Screening, Month 6 and Year 1
|
|
Satisfaction Questionnaire
Periodo de tiempo: Month 6 and Year 1
|
Each participant's satisfaction with the different elements of the study, including the community health coaches, the intervention, and the text messages, will be measured using a questionnaire developed by the investigators.
|
Month 6 and Year 1
|
|
Change in Blood Cholesterol
Periodo de tiempo: Screening, Month 6 and Year 1
|
The Alere Cholestech LDX® Analyzer is engineered to provide accurate, actionable, and readily accessible cholesterol testing results.
The Cholestech uses fingerstick sampling and small sample size (40μL) that makes results less time consuming and easy to obtain.
|
Screening, Month 6 and Year 1
|
|
Change in Pulse
Periodo de tiempo: Screening, Month 6 and Year 1
|
Pulse will be measured using an automatic blood pressure cuff (Omeron, Model BP710 or similar).
Participants will rest for approximately 5 minutes prior to pulse measurement to ensure accurate at rest reading.
|
Screening, Month 6 and Year 1
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Robert L Newton, Jr., PhD, Pennington Biomedical Research Center
Publicaciones y enlaces útiles
Publicaciones Generales
- Nguyen T, Irwin ML, Dewan AT, Cartmel B, Harrigan M, Ferrucci LM, Sanft T, Li F, Lu L, Salinas YD. Examining the effect of obesity-associated gene variants on breast cancer survivors in a randomized weight loss intervention. Breast Cancer Res Treat. 2021 Jun;187(2):487-497. doi: 10.1007/s10549-021-06151-5. Epub 2021 Mar 6.
- Newton RL Jr, Carter LA, Johnson W, Zhang D, Larrivee S, Kennedy BM, Harris M, Hsia DS. A Church-Based Weight Loss Intervention in African American Adults using Text Messages (LEAN Study): Cluster Randomized Controlled Trial. J Med Internet Res. 2018 Aug 24;20(8):e256. doi: 10.2196/jmir.9816.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Actual)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
Otros números de identificación del estudio
- PBRC 2016-018
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .